Dihydropyridine enantiomers block recombinant L-type Ca2+ channels by two different mechanisms

J Physiol. 1999 Nov 15;521 Pt 1(Pt 1):31-42. doi: 10.1111/j.1469-7793.1999.00031.x.

Abstract

1. The molecular basis of the state-dependent block of L-type Ca2+ channels by dihydropyridines is still poorly understood. Therefore, we studied the enantioselectivity of Ca2+ channel block by isradipine enantiomers at three holding potentials (-80, -60 and -40 mV) in Chinese hamster ovary (CHO) cells stably expressing the rabbit lung alpha1C-b-subunit. 2. The extent of enantioselectivity did not markedly change with the holding potential (IC50 ratios of 104-138), whereas the potency of both isradipine enantiomers increased with depolarisation of the holding potential. 3. In addition to its block of the peak Ca2+ channel current, Ipeak, (-)-isradipine inhibited the relative current at the end of the test pulse, the so-called Ilate, normalised to Ipeak (Ilate/Ipeak). This effect was unaffected by the holding potential and revealed distinct kinetics compared to the development of conventional block of Ipeak. 4. When these effects were studied using an alpha1C-b-mutant lacking the high-affinity dihydropyridine binding site, expressed in human embryonic kidney (HEK 293) cells, both enantiomers blocked Ilate/Ipeak to a similar degree. 5. Our data are discussed within the framework of the 'guarded receptor' and the 'modulated receptor' hypotheses. The very different properties of the block of Ilate/Ipeak compared to those of the conventional high-affinity block of Ipeak suggest the existence of an additional mechanism possibly mediated via a second, distinct binding site.

MeSH terms

  • Animals
  • Binding Sites
  • CHO Cells
  • Calcium Channel Blockers / chemistry
  • Calcium Channel Blockers / pharmacology*
  • Calcium Channels, L-Type / drug effects*
  • Calcium Channels, L-Type / metabolism
  • Cell Line
  • Cricetinae
  • Humans
  • Isradipine / chemistry
  • Isradipine / pharmacology*
  • Kinetics
  • Membrane Potentials
  • Models, Biological
  • Rabbits
  • Recombinant Proteins / drug effects
  • Recombinant Proteins / metabolism
  • Stereoisomerism

Substances

  • Calcium Channel Blockers
  • Calcium Channels, L-Type
  • Recombinant Proteins
  • Isradipine